中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
Author:( Guangliang CHEN)

1.Studies on mouse hyperuricemia model

Guangliang CHEN

Chinese Pharmacological Bulletin 1987;0(03):-

2.The progress of study on hyperuricemia

Guangliang CHEN ; Shuyun XU ;

Chinese Pharmacological Bulletin 2003;0(10):-

3.Research progress for animal hyperuricemia model

Guangliang CHEN ; Shuyun XU ;

Chinese Pharmacological Bulletin 1986;0(04):-

4.Progress of hyperhomocysteinemia hazard and pathogenesis

Yanyan DONG ; Guangliang CHEN

Chinese Pharmacological Bulletin 2014;(9):1205-1208

5.Effect of total saponin of Dioscorea on NALP3 inflammasome signaling pathway with acute gouty in rats

Lu WANG ; Sha NA ; Guangliang CHEN

Chinese Pharmacological Bulletin 2017;33(3):354-360

6.Effect of transforming growth factor beta 1/Sma-and Mad-related protein signal pathway in diabetic nephropathy and related drugs:a review

Huiyu JIA ; Zhongnan LI ; Guangliang CHEN

Chinese Journal of Pharmacology and Toxicology 2016;30(3):266-271

7.The experimental animal models of intrauterine growth retardation

Guangliang CHEN ; Lei ZHANG ; Qinmao WANG

Chinese Pharmacological Bulletin 2001;17(1):108-110

8.Determination of the Dissolution of Enalapril Maleate and Folic Acid Tablet

Ping CHEN ; Quanhong YAN ; Guangliang CHEN ; Minqing TIAN

China Pharmacy 2015;26(33):4693-4697

9.THE STUDIES ON PHARMACOKINETICS OF PAEONIFLORIN

Chonghong CHEN ; Yuan ZHANG ; Guangliang CHEN ; Jun LI

Chinese Pharmacological Bulletin 1986;0(05):-

10.Dichotomous roles of microglia in cuprizone-induced demyelination in animal models of multiple sclerosis

Mengru LIANG ; Linlin YIN ; Guangliang CHEN ; Lin LI

Chinese Journal of Comparative Medicine 2014;(8):53-56

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO